Literature DB >> 10326248

Antioxidant properties of EPC-K1: a study on mechanisms.

T Wei1, C Chen, F Li, B Zhao, J Hou, W Xin, A Mori.   

Abstract

Scavenging effects of L-ascorbic acid 2-[3,4-dihydro-2,5,7,8- tetramethyl-2-(4,8,12-trimethytridecyl)-2H-1-benzopyran- 6-yl-hydrogen phosphate] potassium salt (EPC-K1) on hydroxyl radicals, alkyl radicals and lipid radicals were studied with ESR spin trapping techniques. The inhibition effects of EPC-K1 on lipid peroxidation were assessed by TBA assay. The kinetics of EPC-K1 reacting with hydroxyl radicals and linoleic acid radicals were studied by pulse radiolysis. The active site of EPC-K1 and the structure-antioxidative activity relationships were discussed. The superoxide radicals scavenging capacity of the brain homogenate of EPC-K1-treated rats was measured. The results revealed that in comparison with Trolox and vitamin C, EPC-K1 showed better overall antioxidative capacity in vitro and in vivo. EPC-K1 was a moderate scavenger on hydroxyl radicals and alkyl radicals, a potent scavenger on lipid radicals, and an effective inhibitor on lipid peroxidation. EPC-K1 could react with hydroxyl radicals with a rate constant of 7.1 x 10(8) dm3 mol-1 s-1 and react with linoleic acid radicals with a rate constant of 2.8 x 10(6) dm3 mol-1 s-1. The active site of EPC-K1 was the enolic hydroxyl group. After administration of EPC-K1, the ability of rat brain to scavenge superoxide radicals was significantly increased. The potent scavenging effects of EPC-K1 on both hydrophilic and hydrophobic radicals were relevant with its molecular structure, which consisted of both hydrophilic and hydrophobic groups.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10326248     DOI: 10.1016/s0301-4622(99)00017-4

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  3 in total

1.  Imbalance between production and scavenging of hydroxyl radicals in patients maintained on hemodialysis.

Authors:  Sayuri Shirai; Masayuki Ominato; Takekazu Shimazu; Katuhide Toyama; Goichi Ogimoto; Tomoya Fujino; Takashi Yasuda; Takeo Sato; Teruhiko Maeba; Shigeru Owada; Kenjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

Review 2.  Mitochondrial therapeutics for cardioprotection.

Authors:  Raquel S Carreira; Pamela Lee; Roberta A Gottlieb
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 3.  Natural antioxidants for neurodegenerative diseases.

Authors:  Baolu Zhao
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.